Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 8011 AL 8025

Pharmacoutilization data-driven artificial intelligence-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia

Scuteri D, Adornetto C, Greco G, Nicotera P, Bagetta G, Corasaniti MT.

Curr Opin Pharmacol. 2025 Oct;84:102563. doi: 10.1016/j.coph.2025.102563. Epub 2025 Jul 28.

Auditory Hallucinations as the First Symptom of Alzheimer´s Disease - A Case Report

Husing T, Quante A.

Curr Alzheimer Res. 2025;22(11):864-867. doi: 10.2174/0115672050421769250929051818.

Evaluating the Bidirectional Causal Effects of Alzheimer's Disease Across Multiple Conditions: A Systematic Review and Meta-Analysis of Mendelian Randomization Studies

Zhu H, Ni H, Yang Q, Ni J, Ji J, Yang S, Peng F.

Int J Mol Sci. 2025 Apr 10;26(8):3589. doi: 10.3390/ijms26083589.

Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities

Ma M, Jing G, Tian Y, Yin R, Zhang M.

Mol Neurobiol. 2025 Feb;62(2):2435-2449. doi: 10.1007/s12035-024-04417-9. Epub 2024 Aug 7.

The Missing Link in Antiamyloid Therapy

Mandal PK, Maroon JC, Guha Roy R, Patira R, Gogniat MA, Sindhu B.

ACS Chem Neurosci. 2025 Feb 5;16(3):276-280. doi: 10.1021/acschemneuro.4c00825. Epub 2025 Jan 14.

[Pathophysiology and Clinical Presentation of Amyloid-Related Imaging Abnormality Induced by Anti-Amyloid-β Antibody Lecanemab]

Tomimoto H, Matsumoto M, Shiina H, Saeki Y, Niidome T, Nakamura Y.

Brain Nerve. 2025 Feb;77(2):175-187. doi: 10.11477/mf.188160960770020175.

Leveraging mHealth wearables for managing patients with Alzheimer's disease: a scoping review

Noda K, Kageyama I, Kobayashi Y, Lim Y, Sengoku S, Kodama K.

Drug Discov Today. 2025 May;30(5):104363. doi: 10.1016/j.drudis.2025.104363. Epub 2025 Apr 16.

Exploring the role of HIF-1α on pathogenesis in Alzheimer's disease and potential therapeutic approaches

Porel P, Bala K, Aran KR.

Inflammopharmacology. 2025 Feb;33(2):669-678. doi: 10.1007/s10787-024-01585-x. Epub 2024 Oct 27.

The Bidirectional Relationship Between Epilepsy and Alzheimer's Disease

Stewart D, Johnson EL.

Curr Neurol Neurosci Rep. 2025 Feb 8;25(1):18. doi: 10.1007/s11910-025-01404-y.

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia

Magnussen JH.

Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70061. doi: 10.1111/bcpt.70061.

Antiamyloid treatment for dementia: concerns outweigh hopes

Flicker L.

Curr Opin Psychiatry. 2025 Sep 1;38(5):355-360. doi: 10.1097/YCO.0000000000001021. Epub 2025 Jun 9.

Brexpiprazole for the Treatment of Agitation in Older Adults with Alzheimer's Disease: A Systematic Review, Bayesian Meta-analysis, and Meta-regression

da Silva AMP, Falcão L, Ribeiro Gonçalves O, Virgilio Ribeiro F, Machado Magalhães PL, Lee Han M, Łajczak P, Letícia de Bastos Maximiano M, Cal H, de Souza Franco E, de Sousa Maia MB.

CNS Drugs. 2025 Nov;39(11):1071-1082. doi: 10.1007/s40263-025-01219-y. Epub 2025 Aug 31.

Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer's Disease

Chen J, Zhu Z, Xu F, Dou B, Sheng Z, Xu Y.

Cells. 2025 Jan 22;14(3):164. doi: 10.3390/cells14030164.

Early Alzheimer's disease (mild cognitive impairment or mild dementia): Prevalence, diagnostics, treatment options, and guidelines in Asia, Australasia, and Pacific nations countries

Hsu JL, Park KH, Panegyres PK, Huang YH, Eom YI, Prusty V, Tan LS, Shea YF.

J Prev Alzheimers Dis. 2025 Nov;12(9):100362. doi: 10.1016/j.tjpad.2025.100362. Epub 2025 Aug 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias